Sugi Predict

Sugi Predict / Compounds / SCHEMBL7220072

SCHEMBL7220072

SCHEMBL7220072

O=C(C(=O)c1ccc2ccccc2c1)c1ccc2ccccc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 1.00
▸ CES1 P23141 2/20 1.00
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ KDM4E B2RXH2 3/20 0.61
▸ HPGD P15428 2/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ EGFR P00533 1/20 0.61
▸ TP53 P04637 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ MAPT P10636 1/20 0.61
▸ PKM P14618 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ ALOX12 P18054 1/20 0.61
▸ JAK1 P23458 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61
▸ PTPN1 P18031 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31032483 1.00 CES2 (1.00) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL30161362 0.93 CES2 (0.87) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL14876982 0.93 CES2 (0.87) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL31474564 0.91 CES2 (0.83) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL1697489 0.89 CES2 (0.79) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL28671070 0.88 CES2 (0.77) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL2154572 0.87 CES2 (0.76) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL1127250 0.87 CES2 (0.76) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL29613672 0.85 CES2 (0.74) CES2CES1SMN1; SMN2KDM4EHPGD
SCHEMBL30250451 0.85 CES2 (0.74) CES2CES1SMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015374-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-01-15 — — US disclosed
US-12448401-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-10-21 — — US disclosed
WO-2023220463-A1 METHODS OF FORMING AN OBJECT IN A VOLUME OF A PHOTOHARDENABLE COMPOSITION QUADRATIC 3D, INC. (US) 2023-11-16 — — WO disclosed
CN-113227109-A Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting apparatus 株式会社半导体能源研究所 2021-08-06 — — CN disclosed
WO-2020136496-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC INSTRUMENT, AND ILLUMINATION APPARATUS 株式会社半導体エネルギー研究所 2020-07-02 — — WO disclosed
US-8980888-B2 Pyrazole derivative MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2015-03-17 — — US disclosed
EP-2592130-B1 PHOTOCHROMIC MATERIAL MITSUBISHI GAS CHEMICAL CO (JP) 2015-01-21 — — EP disclosed
US-20140378447-A1 NOVEL PYRAZOLE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2014-12-25 — — US disclosed
US-8748629-B2 Photochromic material MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-06-10 — — US disclosed
EP-2592130-A1 PHOTOCHROMIC MATERIAL Mitsubishi Gas Chemical Company, Inc. (JP) 2013-05-15 — — EP disclosed
US-20130102775-A1 PHOTOCHROMIC MATERIAL MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-04-25 — — US disclosed
US-6603007-B1 Intermediates in the fields of pharmaceuticals, agrichemicals, ligands, silver halide photosensitive materials, liquid crystals, surfactants, electrophotography and organic electroluminescence SANKIO CHEMICAL CO., LTD. (JP) 2003-08-05 — — US disclosed
EP-1231207-A1 NOVEL BIPYRIDYL DERIVATIVES Sankio Chemical Co., Ltd. (JP) 2002-08-14 — — EP disclosed
US-20010006759-A1 Polybutadiene containing epoxy group CHARLES R. SHIPLEY JR. 2001-07-05 — — US disclosed
EP-0044115-B2 THERMOSETTING COATING COMPOSITION CONTAINING A BLOCKED ACID CATALYST AKZO N.V. (NL) 1987-06-03 — — EP disclosed
EP-0044115-B1 THERMOSETTING COATING COMPOSITION CONTAINING A BLOCKED ACID CATALYST AKZO N.V. (NL) 1984-10-10 — — EP disclosed
US-4351935-A FOR CURING AN AMINO RESIN AKZO N.V. (NL) 1982-09-28 — — US disclosed
EP-0044115-A1 Thermosetting coating composition containing a blocked acid catalyst AKZO N.V. (NL) 1982-01-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378447-A1 NOVEL PYRAZOLE DERIVATIVE PDE10A, PDE3A, PDE5A CES2 1364/4885CES1 370/4885SMN1; SMN2 1003/4885
US-12448401-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device CHRM1, CYBA, LEF1 CES2 1229/4885CES1 2177/4885SMN1; SMN2 4416/4885
US-20130102775-A1 PHOTOCHROMIC MATERIAL RB1, BRD4, H1-4 CES2 3247/4885CES1 3946/4885SMN1; SMN2 4506/4885
US-20260015374-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device LEF1, NR2E3, ORC3 CES2 2439/4885CES1 2970/4885SMN1; SMN2 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.